The Korea Health Industry Development Institute announced on the 9th that it will hold the "Global Market Entry Success Strategy Seminar for Bio Startups," jointly hosted by Seoul Bio Hub and Chungbuk Creative Economy Innovation Center, on the 19th.


Bosanjin-Seoul Bio Hub Hosts Seminar to Support Global Market Entry View original image

This seminar will feature startup experts, venture capitalists (VCs), lawyers, and bio startup representatives active in the United States and Europe, who will provide advice and know-how to startups preparing for overseas expansion.


In total, 10 speakers will participate both online and offline to deliver thematic lectures and panel discussions. The first lecture will focus on successful cases of entry into the U.S. market, with three speakers: Wooseop Lee, Head of Technology Commercialization Team at Korea Innovation Center (KIC), Ilho Jang, CEO of Stemden, and Yongho Kim, CEO of Ludacure.


Following this, presentations will cover ▲U.S. market entry for bio companies: Frequently Asked Questions (FAQ) and response strategies (Jeonghoon Woo, CEO of BW Biomed) ▲Current status of U.S. bio investment and successful fundraising strategies (Dongmin Yoon, CEO of SolarStar Ventures) ▲Core strategies of smart IP (Juhee Lee, attorney at Fox Rothschild) ▲Challenges and overcoming strategies for bio companies entering the U.S. market (Gyoseok Song, CEO of Medipixel) ▲Growth strategies for global medtech startups (Sumin Jung, CEO of Shaco Neurotech), followed by a panel discussion.


After a short break, the latter part will include sessions sharing insights on ▲The ecosystem of Basel, Switzerland, and collaboration with Korea (Christian Schneider, Director of Basel Innovation Center) ▲Entry into the European and Swiss markets (Valentin Splett, founder and CEO of Peak Spirit).


Additionally, after the seminar, a luncheon will provide an opportunity for offline speakers and attendees to engage in business networking, facilitating active exchange of practical information and personal connections not covered during the seminar.



This seminar, targeting bio and medical startups and small and medium-sized venture business workers interested in overseas expansion, will accept applications through the Seoul Bio Hub website until the 18th. Participation is available either onsite or online; onsite attendance is limited to the first 100 applicants, and online participants will be provided with a separate live streaming access link.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing